Literature DB >> 15472837

Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole.

Rajesh M Prabhu1, Mark Bonnell, Bradford L Currier, Robert Orenstein.   

Abstract

A 31-year-old Jamaican man with disseminated nonmeningeal coccidioidomycosis that involved the spine, ribs, pelvis, liver, and spleen did not clinically respond to a prolonged course of both amphotericin B deoxycholate and liposomal amphotericin B therapy. After institution of voriconazole monotherapy, the patient had a favorable (albeit slow) radiological and clinical response without adjunctive surgical intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15472837     DOI: 10.1086/424019

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

Review 2.  Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.

Authors:  Chinh Nguyen; Bridget Marie Barker; Susan Hoover; David E Nix; Neil M Ampel; Jeffrey A Frelinger; Marc J Orbach; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil.

Authors:  R A Cordeiro; R S N Brilhante; M F G Rocha; M A B Fechine; A K F Costa; Z P Camargo; J J C Sidrim
Journal:  Mycopathologia       Date:  2006-01       Impact factor: 2.574

4.  Coccidioidomycosis causing osteomyelitis of the hand in an immunocompetent patient.

Authors:  Jens U Berli; Wayne N Campbell; Ryan D Katz
Journal:  Hand (N Y)       Date:  2015-09

5.  Voriconazole use for endemic fungal infections.

Authors:  Alison Freifeld; Laurie Proia; David Andes; Larry M Baddour; Janis Blair; Brad Spellberg; Sandra Arnold; Arnold Lentnek; L Joseph Wheat
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

6.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

Review 7.  The public health impact of coccidioidomycosis in Arizona and California.

Authors:  Richard F Hector; George W Rutherford; Clarisse A Tsang; Laura M Erhart; Orion McCotter; Shoana M Anderson; Kenneth Komatsu; Farzaneh Tabnak; Duc J Vugia; Ying Yang; John N Galgiani
Journal:  Int J Environ Res Public Health       Date:  2011-04-15       Impact factor: 3.390

Review 8.  A paradigm for the evaluation and management of spinal coccidioidomycosis.

Authors:  Nikolay L Martirosyan; Jesse M Skoch; Orel Zaninovich; Carmine Zoccali; John N Galgiani; Ali A Baaj
Journal:  Surg Neurol Int       Date:  2015-06-17

9.  Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole.

Authors:  Dae Won Park; Jang Wook Sohn; Hee Jin Cheong; Woo Joo Kim; Min Ja Kim; Je Hyeong Kim; Chol Shin
Journal:  BMC Infect Dis       Date:  2006-02-15       Impact factor: 3.090

10.  Voriconazole in the management of nosocomial invasive fungal infections.

Authors:  Javier Pemán; Miguel Salavert; Emilia Cantón; Isidro Jarque; Eva Romá; Rafael Zaragoza; Angel Viudes; Miguel Gobernado
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.